Is a complete MMED research report available?

No complete published report is available for MiniMed Group, Inc. (MMED) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

MiniMed Group, Inc. (MMED)

NASDAQ: MMED · USD

$19.1

+0.20 (+1.1%)· Recorded snapshot

Market cap	5.4B
Revenue (ttm)	3.2B
Net income (ttm)	-314M
EPS (ttm)	-$1.19
Shares out	281.3M
P/E (forward)	31.7x
Volume	9,316,342

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 3.2B
Net income (ttm): -314M
EPS (ttm): -$1.19
P/E (forward): 31.7x
Market cap: 5.4B

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Conserver

Metric	Value
Amount currency	USD
CIK code	0002062583
Company name	MiniMed Group, Inc.
Country	United States
Country code	US
CUSIP number	60365F109
Earnings date	2026-11-10
Earnings time	amc
Employees	8,000
Employees change	0
Employees growth	0%
Enterprise value	$5.2B
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-07-31
First seen	2026-05-09
Fiscal year end	April
Founded	1983
In index	RUSSELL2000
Industry	Medical Instruments & Supplies
IPO date	2026-03-06
Is primary listing	Yes
Is SPAC	No
ISIN number	US60365F1093
Last 10-K release date	2026-06-29
Last earnings date	2026-09-01
Last refreshed	2026-10-28
Last stock split type	Never
Market cap	$5.4B
Market cap category	Mid-Cap
Next earnings date	2026-11-10
Options	Yes
Price	$19.14
Price currency	USD
Sector	Healthcare
SIC code	3841
Stock price date	2026-10-28
Symbol	MMED
U.S. state	California
Website	https://www.minimed.com

Metric

Value

Amount currency

USD

CIK code

0002062583

Company name

MiniMed Group, Inc.

Country

United States

Country code

CUSIP number

60365F109

Earnings date

2026-11-10

Earnings time

amc

Employees

8,000

Employees change

Employees growth

Enterprise value

$5.2B

Exchange

NASDAQ

Financial currency

USD

Financial report date

2026-07-31

First seen

2026-05-09

Fiscal year end

April

Founded

1983

In index

RUSSELL2000

Industry

Medical Instruments & Supplies

IPO date

2026-03-06

Is primary listing

Yes

Is SPAC

ISIN number

US60365F1093

Last 10-K release date

2026-06-29

Last earnings date

2026-09-01

Last refreshed

2026-10-28

Last stock split type

Never

Market cap

$5.4B

Market cap category

Mid-Cap

Next earnings date

2026-11-10

Options

Yes

Price

$19.14

Price currency

USD

Sector

Healthcare

SIC code

3841

Stock price date

2026-10-28

Symbol

MMED

U.S. state

California

Website

https://www.minimed.com

Metric	Value
Earnings yield	-6.24%
EV/EBIT	41.21x
EV/EBITDA	18.44x
EV/Sales	1.64x
FCF / EV yield	-5.99%
FCF yield	-5.83%
Forward EV/Sales	1.52x
Forward P/E	31.74x
Forward P/S	1.56x
Industry forward P/E	22.82x
Industry P/E	66.22x
P/B ratio	1.47x
P/S ratio	1.68x
Price / tangible book value	4.29x
Price/EBITDA ratio	18.96x
Sector forward P/E	23.56x
Sector P/E	50.08x

Metric

Value

Earnings yield

-6.24%

EV/EBIT

41.21x

EV/EBITDA

18.44x

EV/Sales

1.64x

FCF / EV yield

-5.99%

FCF yield

-5.83%

Forward EV/Sales

1.52x

Forward P/E

31.74x

Forward P/S

1.56x

Industry forward P/E

22.82x

Industry P/E

66.22x

P/B ratio

1.47x

P/S ratio

1.68x

Price / tangible book value

4.29x

Price/EBITDA ratio

18.96x

Sector forward P/E

23.56x

Sector P/E

50.08x

Metric	Value
EBIT margin	3.97%
EBITDA margin	8.88%
Gross margin	56.89%
Operating margin	3.97%
Pretax margin	-5.34%
Profit margin	-9.75%
Profit per employee	$-39,250
Revenue per employee	$402,750
ROCE	3.25%
ROE	-8.66%
ROIC	2.26%
SBC / revenue	1.46%
Tax / revenue	4%

Metric

Value

EBIT margin

3.97%

EBITDA margin

8.88%

Gross margin

56.89%

Operating margin

3.97%

Pretax margin

-5.34%

Profit margin

-9.75%

Profit per employee

$-39,250

Revenue per employee

$402,750

ROCE

3.25%

ROE

-8.66%

ROIC

2.26%

SBC / revenue

1.46%

Tax / revenue

Metric	Value
EPS growth years	0
Gross profit growth	17.01%
Gross profit growth (Q)	14.53%
Net income growth years	0
Operating income growth	208.43%
Operating income growth (Q)	-87.5%
Revenue growth	15.65%
Revenue growth (Q)	16.6%
Revenue growth (QoQ)	0.72%
Revenue growth quarters	3
Revenue growth years	3

Metric

Value

EPS growth years

Gross profit growth

17.01%

Gross profit growth (Q)

14.53%

Net income growth years

Operating income growth

208.43%

Operating income growth (Q)

-87.5%

Revenue growth

15.65%

Revenue growth (Q)

16.6%

Revenue growth (QoQ)

0.72%

Revenue growth quarters

Revenue growth years

Metric	Value
Capital expenditures	$-211M
Depreciation and amortization	$158M
EBIT	$128M
EBITDA	$286M
EPS	$-1.19
FCF per share	$-1.12
Financing cash flow	$514M
Free cash flow	$-316M
Free cash flow minus SBC	$-363M
Gross profit	$1.8B
Income taxes	$129M
Investing cash flow	$-211M
Net cash flow	$198M
Net income	$-314M
Operating cash flow minus SBC	$-152M
Operating income	$128M
Revenue	$3.2B
Stock-based compensation	$47M

Metric

Value

Capital expenditures

$-211M

Depreciation and amortization

$158M

EBIT

$128M

EBITDA

$286M

EPS

$-1.19

FCF per share

$-1.12

Financing cash flow

$514M

Free cash flow

$-316M

Free cash flow minus SBC

$-363M

Gross profit

$1.8B

Income taxes

$129M

Investing cash flow

$-211M

Net cash flow

$198M

Net income

$-314M

Operating cash flow minus SBC

$-152M

Operating income

$128M

Revenue

$3.2B

Stock-based compensation

$47M

Metric	Value
Altman Z-Score	3.12
Book value per share	$12.87
Debt / EBITDA	0.2
Debt / equity	0.02
Goodwill	$2.3B
Long-term assets	$3.3B
Long-term liabilities	$316M
Net cash (debt)	$148M
Net cash / market cap	2.73%
Net debt / EBITDA	-0.52
Net debt / equity	-0.04
Piotroski F-Score	2
Property, plant and equipment	$793M
Shareholders' equity	$3.6B
Tangible book value	$1.3B
Tangible book value per share	$4.50
Total assets	$4.7B
Total cash	$207M
Total debt	$59M
Total liabilities	$1.1B

Metric

Value

Altman Z-Score

3.12

Book value per share

$12.87

Debt / EBITDA

0.2

Debt / equity

0.02

Goodwill

$2.3B

Long-term assets

$3.3B

Long-term liabilities

$316M

Net cash (debt)

$148M

Net cash / market cap

2.73%

Net debt / EBITDA

-0.52

Net debt / equity

-0.04

Piotroski F-Score

Property, plant and equipment

$793M

Shareholders' equity

$3.6B

Tangible book value

$1.3B

Tangible book value per share

$4.50

Total assets

$4.7B

Total cash

$207M

Total debt

$59M

Total liabilities

$1.1B

Metric	Value
Current assets	$1.4B
Current liabilities	$782M
Current ratio	1.81
Net working capital	$437M
Quick ratio	1.26
Working capital	$635M
Working capital turnover	7.46

Metric

Value

Current assets

$1.4B

Current liabilities

$782M

Current ratio

1.81

Net working capital

$437M

Quick ratio

1.26

Working capital

$635M

Working capital turnover

7.46

Metric	Value
Buyback yield / dilution	-4.29%
Dividend yield	0%
Shareholder yield	-4.29%

Metric

Value

Buyback yield / dilution

-4.29%

Dividend yield

Shareholder yield

-4.29%

Metric	Value
150-day SMA	$16.53
1D price change	1.08%
1M price change	-4.23%
1M total return	-4.23%
1W price change	7.5%
1W total return	7.5%
20-day SMA	$18.68
3M price change	8.29%
3M total return	8.29%
50-day SMA	$20.21
52-week high	$24.43
52-week high date	2026-09-02
52-week low	$10.65
52-week low date	2026-05-15
6M price change	48.1%
6M total return	48.1%
All-time high	$24.43
All-time high date	2026-09-02
All-time low	$10.65
All-time low date	2026-05-15
Average true range (ATR)	$0.86
Average volume	17.8M
Beta (1Y)	0.42
Change from 52-week high	-21.67%
Change from 52-week low	79.67%
Change from all-time high	-21.67%
Change from all-time low	79.67%
Change from open	1.35%
Day's gap	-0.26%
Dollar volume	$178.3M
High price	$19.31
Low price	$18.65
Monthly RSI	0
Open price	$18.88
Position in 52-week range	73.48%
Premarket change	-1.27%
Premarket close	$18.93
Premarket price	$18.69
Premarket volume	28.6K
Previous close	$18.93
Price vs 150-day SMA	15.75%
Price vs 20-day SMA	2.42%
Price vs 50-day SMA	-5.32%
Relative volume	0.53
Return from IPO open	1.18%
Return from IPO price	-3.63%
RSI	50.79
Sharpe ratio	0.3
Sortino ratio	0.58
Volume	9.3M
Weekly RSI	49.36

Metric

Value

150-day SMA

$16.53

1D price change

1.08%

1M price change

-4.23%

1M total return

-4.23%

1W price change

7.5%

1W total return

7.5%

20-day SMA

$18.68

3M price change

8.29%

3M total return

8.29%

50-day SMA

$20.21

52-week high

$24.43

52-week high date

2026-09-02

52-week low

$10.65

52-week low date

2026-05-15

6M price change

48.1%

6M total return

48.1%

All-time high

$24.43

All-time high date

2026-09-02

All-time low

$10.65

All-time low date

2026-05-15

Average true range (ATR)

$0.86

Average volume

17.8M

Beta (1Y)

0.42

Change from 52-week high

-21.67%

Change from 52-week low

79.67%

Change from all-time high

-21.67%

Change from all-time low

79.67%

Change from open

1.35%

Day's gap

-0.26%

Dollar volume

$178.3M

High price

$19.31

Low price

$18.65

Monthly RSI

Open price

$18.88

Position in 52-week range

73.48%

Premarket change

-1.27%

Premarket close

$18.93

Premarket price

$18.69

Premarket volume

28.6K

Previous close

$18.93

Price vs 150-day SMA

15.75%

Price vs 20-day SMA

2.42%

Price vs 50-day SMA

-5.32%

Relative volume

0.53

Return from IPO open

1.18%

Return from IPO price

-3.63%

RSI

50.79

Sharpe ratio

0.3

Sortino ratio

0.58

Volume

9.3M

Weekly RSI

49.36

Metric	Value
Float	281.3M
Float percentage	99.97%
Shares change (QoQ)	4.81%
Shares change (YoY)	4.29%
Shares held by insiders	0.03%
Shares held by institutions	13.63%
Shares outstanding	281.3M
Short % of float	6.47%
Short % of shares	6.47%
Short ratio	6.1 days

Metric

Value

Float

281.3M

Float percentage

99.97%

Shares change (QoQ)

4.81%

Shares change (YoY)

4.29%

Shares held by insiders

0.03%

Shares held by institutions

13.63%

Shares outstanding

281.3M

Short % of float

6.47%

Short % of shares

6.47%

Short ratio

6.1 days

MiniMed Group, Inc. (MMED)

Price

Financial snapshot

Fair-value bridge

Latest news · MMED

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All MMED indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on MMED

Frequently asked questions